ELEV – elevation oncology, inc. - common stock (US:AMEX)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ELEV

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/6

07:30 am

elev

Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements

Low Report

Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements

Report

9/23

07:30 am

elev

Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2

High Report

Report

9/3

07:30 am

elev

Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Medium Report

Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.